PMID- 8674108 OWN - NLM STAT- MEDLINE DCOM- 19960814 LR - 20240104 IS - 0092-8674 (Print) IS - 0092-8674 (Linking) VI - 85 IP - 7 DP - 1996 Jun 28 TI - The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. PG - 1009-23 AB - Mutations of the BRCA1 gone in humans are associated with predisposition to breast and ovarian cancers. We show here that Brca1+/- mice are normal and fertile and lack tumors by age eleven months. Homozygous Brca1(5-6) mutant mice die before day 7.5 of embryogenesis. Mutant embryos are poorly developed, with no evidence of mesoderm formation. The extraembryonic region is abnormal, but aggregation with wild-type tetraploid embryos does not rescue the lethality. In vivo, mutant embryos do not exhibit increased apoptosis but show reduced cell proliferation accompanied by decreased expression of cyclin E and mdm-2, a regulator of p53 activity. The expression of cyclin-dependent kinase inhibitor p21 is dramatically increased in the mutant embryos. Buttressing these in vivo observations is the fact that mutant blastocyst growth is grossly impaired in vitro. Thus, the death of Brca1(5-6) mutant embryos prior to gastrulation may be due to a failure of the proliferative burst required for the development of the different germ layers. FAU - Hakem, R AU - Hakem R AD - Amgen Institute, Toronto, Ontario, Canada. FAU - de la Pompa, J L AU - de la Pompa JL FAU - Sirard, C AU - Sirard C FAU - Mo, R AU - Mo R FAU - Woo, M AU - Woo M FAU - Hakem, A AU - Hakem A FAU - Wakeham, A AU - Wakeham A FAU - Potter, J AU - Potter J FAU - Reitmair, A AU - Reitmair A FAU - Billia, F AU - Billia F FAU - Firpo, E AU - Firpo E FAU - Hui, C C AU - Hui CC FAU - Roberts, J AU - Roberts J FAU - Rossant, J AU - Rossant J FAU - Mak, T W AU - Mak TW LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Cell JT - Cell JID - 0413066 RN - 0 (BRCA1 Protein) RN - 0 (Cdkn1a protein, mouse) RN - 0 (Cyclin-Dependent Kinase Inhibitor p21) RN - 0 (Cyclins) RN - 0 (Enzyme Inhibitors) RN - 0 (Neoplasm Proteins) RN - 0 (Nuclear Proteins) RN - 0 (Proto-Oncogene Proteins) RN - 0 (Transcription Factors) RN - 0 (Tumor Suppressor Protein p53) RN - EC 2.3.2.27 (Mdm2 protein, mouse) RN - EC 2.3.2.27 (Proto-Oncogene Proteins c-mdm2) SB - IM MH - Alternative Splicing/physiology MH - Animals MH - Apoptosis/genetics MH - BRCA1 Protein MH - Base Sequence MH - Cell Division/genetics MH - Cyclin-Dependent Kinase Inhibitor p21 MH - Cyclins/genetics MH - Embryo, Mammalian/*cytology/physiology MH - Enzyme Inhibitors/metabolism MH - Exons/genetics MH - Female MH - Gene Expression/physiology MH - Genes, Lethal/physiology MH - Genes, Tumor Suppressor/genetics MH - Genetic Carrier Screening MH - Male MH - Mammary Neoplasms, Experimental/*genetics MH - Mesoderm/cytology/physiology MH - Mice MH - Mice, Inbred C3H MH - Mice, Inbred C57BL MH - Mice, Mutant Strains MH - Molecular Sequence Data MH - Mutation/physiology MH - Neoplasm Proteins/*genetics MH - *Nuclear Proteins MH - Phenotype MH - Proto-Oncogene Proteins/genetics MH - Proto-Oncogene Proteins c-mdm2 MH - Transcription Factors/*genetics MH - Trophoblasts/cytology/physiology MH - Tumor Suppressor Protein p53/genetics EDAT- 1996/06/28 00:00 MHDA- 1996/06/28 00:01 CRDT- 1996/06/28 00:00 PHST- 1996/06/28 00:00 [pubmed] PHST- 1996/06/28 00:01 [medline] PHST- 1996/06/28 00:00 [entrez] AID - S0092-8674(00)81302-1 [pii] AID - 10.1016/s0092-8674(00)81302-1 [doi] PST - ppublish SO - Cell. 1996 Jun 28;85(7):1009-23. doi: 10.1016/s0092-8674(00)81302-1.